OABIW
IndustrialsOmniAb, Inc. Warrant
Live · NASDAQ · Mar 28, 6:08 AM
What's Moving OABIW Today?
No AI insight has been generated for OABIW yet. Check back soon — insights are generated from recent news analysis.
Generated Insights
No insights have been generated for OABIW yet. Check back soon.
OABIW News
20 articles- OmniAb to Participate at the Leerink Partners Global Healthcare ConferenceYahoo Finance·Feb 24, 2026
- OmniAb to Report Fourth Quarter 2025 Financial Results on March 4Yahoo Finance·Feb 19, 2026
- John Higgins Bought 3.5% More Shares In OmniAbYahoo Finance·Nov 13, 2025
- Analysts Have Been Trimming Their OmniAb, Inc. (NASDAQ:OABI) Price Target After Its Latest ReportYahoo Finance·Nov 8, 2025
- OmniAb (OABI): Rapid 30.4% Revenue Growth Forecast Raises Questions for Loss-Weary InvestorsYahoo Finance·Nov 6, 2025
- OmniAb Inc (OABI) Q3 2025 Earnings Call Highlights: Strong Program Momentum Amid Revenue DeclineYahoo Finance·Nov 5, 2025
- OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance·Nov 4, 2025
- OmniAb Reports Third Quarter 2025 Financial Results and Business HighlightsYahoo Finance·Nov 4, 2025
- OmniAb, Inc. (OABI) Expected to Beat Earnings Estimates: Should You Buy?Yahoo Finance·Oct 28, 2025
- Insider Stock Buying Reaches US$1.48m On OmniAbYahoo Finance·Oct 28, 2025
- OmniAb to Participate in Three Investor Conferences in NovemberYahoo Finance·Oct 16, 2025
- OmniAb to Report Third Quarter 2025 Financial Results on November 4Yahoo Finance·Oct 14, 2025
- OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment ConferenceYahoo Finance·Sep 2, 2025
- OmniAb Announces $30 Million Private PlacementYahoo Finance·Aug 25, 2025
- Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing TreatmentsYahoo Finance·Aug 20, 2025
- OmniAb Second Quarter 2025 Earnings: Revenues DisappointYahoo Finance·Aug 9, 2025
- OmniAb, Inc. (OABI) Reports Q2 Loss, Lags Revenue EstimatesYahoo Finance·Aug 6, 2025
- OmniAb Reports Second Quarter 2025 Financial Results and Business HighlightsYahoo Finance·Aug 6, 2025
- Real Brokerage And 2 Other Compelling Penny Stocks To ConsiderYahoo Finance·Aug 6, 2025
- OmniAb to Report Second Quarter 2025 Financial Results on August 6Yahoo Finance·Jul 16, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About OmniAb, Inc. Warrant
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.